HIT Consultant December 11, 2024
What You Should Know:
– Nucs AI, a company that uses AI in precision medicine for the diagnosis and treatment of prostate cancer, today announces that it has closed a $3.5 million seed round of funding.
– The company will use the funding to further build out its platform and to support FDA clearance for its technology in the United States.
Nucs AI: Transforming Prostate Cancer Diagnosis and Treatment with Precision Medicine
Founded in 2023, Nucs AI is pioneering advancements in prostate cancer care through the integration of precision medicine and artificial intelligence (AI). With global prostate cancer cases projected to double between 2020 and 2040, the company aims to revolutionize patient outcomes by optimizing the use of prostate-specific...
Today's Sponsors
Today's Sponsor